JAMES GRATTAN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LUBBOCK, TX NPI 1841293370

General Payments — all program years on this page

$16,053.85

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 154
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $443.95 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $443.9517

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $11,472.2927
2019 $2,599.9722
2020 $519.8131
2021 $180.9112
2022 $416.9728
2023 $419.9517
2024 $443.9517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086897213 Novartis Pharmaceuticals Corporation $14.28 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897215 Novartis Pharmaceuticals Corporation $6.95 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897217 Novartis Pharmaceuticals Corporation $24.37 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897235 Novartis Pharmaceuticals Corporation $20.32 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897253 Novartis Pharmaceuticals Corporation $16.61 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897259 Novartis Pharmaceuticals Corporation $22.67 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897273 Novartis Pharmaceuticals Corporation $23.88 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086897281 Novartis Pharmaceuticals Corporation $26.92 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092644305 Boston Scientific Corporation $35.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096910383 Novo Nordisk Inc $15.67 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101749117 E.R. Squibb & Sons, L.L.C. $18.60 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111588538 Amgen Inc. $13.88 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111588540 Amgen Inc. $20.44 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116752893 Endologix LLC $121.66 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118177210 Boehringer Ingelheim Pharmaceuticals, Inc. $16.66 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125298669 Abbott Laboratories $24.03 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128529458 Surmodics, Inc. $21.23 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.